Actress Olivia Munn shares that her mother has also been diagnosed with breast cancer, following her own previous revelations about her breast cancer experience.

In a poignant turn of events, actress Olivia Munn's 2024 diagnosis with Luminal B breast cancer has underscored the importance of the Tyrer-Cuzick Risk Assessment test. This tool, which provides a personalised lifetime risk estimate for breast cancer, has proven to be a valuable asset in early detection and timely treatment.

The Tyrer-Cuzick Risk Assessment test analyses multiple factors, including personal health history, family history, breast density, and hormone therapy usage during menopause. It goes beyond standard screening methods like mammograms by offering a comprehensive risk score that can guide both patients and doctors in making informed decisions about breast cancer surveillance and prevention.

One of the test's key advantages is its incorporation of breast density, a known factor that increases breast cancer risk and makes early tumours harder to detect on mammograms. This offers a clearer and more personalised risk profile, with individuals identified with dense breast tissue potentially benefiting from additional imaging modalities like automated whole breast ultrasound.

The test's significance is vividly illustrated by Olivia Munn's experience. Despite clear mammograms and ultrasounds, Munn's Stage 1 breast cancer was detected only after her doctor used the Tyrer-Cuzick test, which indicated a high-risk score. This led to further imaging with MRI and an early diagnosis that might have been missed otherwise.

While the test is not without its limitations—it may underestimate risk in some populations, such as Black women—it nonetheless adds significant value by supplementing routine screening, identifying high-risk individuals, and enabling earlier and potentially life-saving interventions.

Munn's mother, Kim, was also diagnosed with Stage 1 Her2 breast cancer. After her diagnosis, Munn urged her mother and sister to take the Breast Cancer Lifetime Risk Assessment test. Munn's mother's score was 26.2%, prompting Munn to insist on an MRI despite a clear yearly mammogram. Munn's mother has since completed 12 rounds of chemotherapy treatment and is currently undergoing additional transfusion treatment, which will continue until the fall.

In a heartfelt gesture, Munn shared a link to The Tyrer-Cuzick Risk Assessment test on her Instagram page, expressing hope that sharing her mother's story will help save someone's life. Munn's husband, comedian John Mulaney, was by her side during her treatment, which included a double mastectomy and a hysterectomy.

Munn has been advocating for a breast cancer risk assessment test for over a year, emphasising the importance of early detection and personalised care. She extends her gratitude to those who take care of others during difficult times, and encourages everyone to prioritise their health and wellbeing.

In conclusion, the Tyrer-Cuzick Risk Assessment test offers a proactive approach to breast cancer risk, enabling better prevention efforts and improving the chances of catching breast cancer at its most treatable stages. The test is a free, online tool that estimates a woman's risk of developing breast cancer over the next five years and lifetime. It's a valuable resource for anyone concerned about their breast health or with a family history of breast cancer.

The Tyrer-Cuzick Risk Assessment test, which provides a personalized lifetime risk estimate for breast cancer, goes beyond standard screening methods like mammograms by offering a comprehensive risk score that can guide both patients and doctors in making informed decisions about breast cancer surveillance and prevention.
In a heartfelt gesture, actress Olivia Munn, who was diagnosed with Luminal B breast cancer in 2024, shared a link to The Tyrer-Cuzick Risk Assessment test on her Instagram page, expressing hope that sharing her mother's story will help save someone's life.
Olivia Munn's mother, Kim, was also diagnosed with Stage 1 Her2 breast cancer. After her diagnosis, Munn urged her mother and sister to take the Breast Cancer Lifetime Risk Assessment test. Munn's mother's score was 26.2%, prompting Munn to insist on an MRI despite a clear yearly mammogram.
The Tyrer-Cuzick Risk Assessment test analyses multiple factors, including personal health history, family history, breast density, and hormone therapy usage during menopause, and is not without its limitations—it may underestimate risk in some populations, such as Black women—but it nonetheless adds significant value by supplementing routine screening, identifying high-risk individuals, and enabling earlier and potentially life-saving interventions.